(Q27322781)

English

EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALS

scientific article

Statements

EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALS (English)
0 references
0 references
Claire E Le Pichon
0 references
Sara L Dominguez
0 references
Hilda Solanoy
0 references
Hai Ngu
0 references
Nicholas Lewin-Koh
0 references
Mark Chen
0 references
Ryan Watts
0 references
Kimberly Scearce-Levie
0 references
2013
0 references
0 references
8
0 references
4
0 references
e62342
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit